Recurrence of prostate cancer of rare location: magnetic resonance diagnosis and treatment. Clinical case

Prostate cancer (PCa) is the second most common cancer in the world, with a steady increase in incidence every year. Regardless of the chosen treatment method for patients with localized PCa, the development of local relapse occurs in at least 15 % of cases. The key point in monitoring patients with PCa today is dynamic monitoring of prostate-specific antigen levels. When biochemical recurrence is detected, the subsequent diagnostic algorithm strategy should be aimed at visualizing the tumor site, which can be local, in the lymph nodes, or metastatic. Multiparametric magnetic resonance imaging can serve as a method for diagnosing and monitoring relapses of PCa located locally or in the lymph nodes of the pelvis. When assessing relapses located in the pelvic area, one should remember possible rare sites of their localization, as demonstrated in our clinical case. The optimal treatment for recurrent PCa is still controversial and requires further study.

Authors

Institutions

Publication Details

Journal
Cancer Urology
Published
2024-12-01
DOI
https://doi.org/10.17650/1726-9776-2024-20-4-90-97
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrence of prostate cancer of rare location: magnetic resonance diagnosis and treatment. Clinical case

A.V. Kriger, A. D. Tsibulskii, V. А. Solodkiy, A. Yu. Pavlov et al.
1 links
Cancer Urology
Prostate Cancer Diagnosis and Treatment
article

Recurrence of prostate cancer of rare location: magnetic resonance diagnosis and treatment. Clinical case

A.V. Kriger, A. D. Tsibulskii, V. А. Solodkiy, A. Yu. Pavlov, V. A. Rebrikova
article en

Abstract

Prostate cancer (PCa) is the second most common cancer in the world, with a steady increase in incidence every year. Regardless of the chosen treatment method for patients with localized PCa, the development of local relapse occurs in at least 15 % of cases. The key point in monitoring patients with PCa today is dynamic monitoring of prostate-specific antigen levels. When biochemical recurrence is detected, the subsequent diagnostic algorithm strategy should be aimed at visualizing the tumor site, which can be local, in the lymph nodes, or metastatic. Multiparametric magnetic resonance imaging can serve as a method for diagnosing and monitoring relapses of PCa located locally or in the lymph nodes of the pelvis. When assessing relapses located in the pelvic area, one should remember possible rare sites of their localization, as demonstrated in our clinical case. The optimal treatment for recurrent PCa is still controversial and requires further study.

Cancer UrologyVol. 20(4)
Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology (RU), Ministry of Health of the Russian Federation (RU)
Openalex Percentile: Top 55%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Recurrence of prostate cancer of rare location: magnetic resonance diagnosis and treatment. Clinical case — A.V. Kriger, A. D. Tsibulskii, et al. · Cancer Urology (2024) | TGRS Research Map | TGRS